Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Rizzo

Showing results (21-30 of 381) with videos related to

Pageof 39
Sort By:
Medicina (Kaunas, Lithuania)|March 3, 2021
Novel Targeted Therapies for Advanced CholangiocarcinomaAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|March 23, 2021
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature reviewAlessandro Rizzo, Giovanni Brandi
Diseases (Basel, Switzerland)|March 27, 2024
Lifestyle Profiles of Italian Oncology Nurses according to Sex, Work Experience and Shift: An Exploratory StudyElsa Vitale, Alessandro Rizzo
Expert Review of Gastroenterology & Hepatology|February 11, 2021
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancerAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 7, 2021
Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinomaAlessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|December 14, 2020
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of careAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|March 8, 2021
A foreword on biliary tract cancers: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|February 24, 2022
Foreword: hepatocellular carcinoma: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Gennaro Palmiotti
JCO Precision Oncology|March 16, 2022
FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary CenterAlessandro Rizzo, Giovanni Brandi
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
Radiofrequency ablation, radiation therapy, transarterial chemoembolization, and yttrium 90: no differences for local treatment of liver cancer?Alessandro Rizzo, Giovanni Brandi
Pageof 39

Showing results (21-30 of 381) with videos related to

Sort By:
Pageof 39
Medicina (Kaunas, Lithuania)|March 3, 2021
Novel Targeted Therapies for Advanced CholangiocarcinomaAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|March 23, 2021
Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature reviewAlessandro Rizzo, Giovanni Brandi
Diseases (Basel, Switzerland)|March 27, 2024
Lifestyle Profiles of Italian Oncology Nurses according to Sex, Work Experience and Shift: An Exploratory StudyElsa Vitale, Alessandro Rizzo
Expert Review of Gastroenterology & Hepatology|February 11, 2021
Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancerAlessandro Rizzo, Giovanni Brandi
Cancer Treatment and Research Communications|February 7, 2021
Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinomaAlessandro Rizzo, Giovanni Brandi
Expert Review of Gastroenterology & Hepatology|December 14, 2020
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of careAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|March 8, 2021
A foreword on biliary tract cancers: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Giovanni Brandi
Expert Opinion on Investigational Drugs|February 24, 2022
Foreword: hepatocellular carcinoma: emerging treatments, drug targets, and fundamental knowledge gapsAlessandro Rizzo, Gennaro Palmiotti
JCO Precision Oncology|March 16, 2022
FGFR Inhibitors in Cholangiocarcinoma: A Real-World Experience at a Tertiary CenterAlessandro Rizzo, Giovanni Brandi
Acta Oncologica (Stockholm, Sweden)|March 7, 2022
Radiofrequency ablation, radiation therapy, transarterial chemoembolization, and yttrium 90: no differences for local treatment of liver cancer?Alessandro Rizzo, Giovanni Brandi
Pageof 39